School-Based Malaria Screening and Treatment Reduces Plasmodium falciparum Infection and Anemia Prevalence in Two Transmission Settings in Malawi
- PMID: 35290461
- PMCID: PMC9373151
- DOI: 10.1093/infdis/jiac097
School-Based Malaria Screening and Treatment Reduces Plasmodium falciparum Infection and Anemia Prevalence in Two Transmission Settings in Malawi
Abstract
Background: In areas highly endemic for malaria, Plasmodium falciparum infection prevalence peaks in school-age children, adversely affecting health and education. School-based intermittent preventive treatment reduces this burden but concerns about cost and widespread use of antimalarial drugs limit enthusiasm for this approach. School-based screening and treatment is an attractive alternative. In a prospective cohort study, we evaluated the impact of school-based screening and treatment on the prevalence of P. falciparum infection and anemia in 2 transmission settings.
Methods: We screened 704 students in 4 Malawian primary schools for P. falciparum infection using rapid diagnostic tests (RDTs), and treated students who tested positive with artemether-lumefantrine. We determined P. falciparum infection by microscopy and quantitative polymerase chain reaction (qPCR), and hemoglobin concentrations over 6 weeks in all students.
Results: Prevalence of infection by RDT screening was 37% (9%-64% among schools). An additional 9% of students had infections detected by qPCR. Following the intervention, significant reductions in infections were detected by microscopy (adjusted relative reduction [aRR], 48.8%; P < .0001) and qPCR (aRR, 24.5%; P < .0001), and in anemia prevalence (aRR, 30.8%; P = .003). Intervention impact was reduced by infections not detected by RDT and new infections following treatment.
Conclusions: School-based screening and treatment reduced P. falciparum infection and anemia. This approach could be enhanced by repeating screening, using more-sensitive screening tests, and providing longer-acting drugs.
Clinical trials registration: NCT04858087.
Keywords: adolescent; anemia; chemoprevention; intervention; schoolchildren.
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Conflict of interest statement
Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures


Similar articles
-
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.Cochrane Database Syst Rev. 2014 Jun 30;(6):CD008152. doi: 10.1002/14651858.CD008152.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2015 Feb 19;(2):CD008152. doi: 10.1002/14651858.CD008152.pub4. PMID: 24979199 Free PMC article. Updated.
-
Primaquine for reducing Plasmodium falciparum transmission.Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008152. doi: 10.1002/14651858.CD008152.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2014 Jun 30;(6):CD008152. doi: 10.1002/14651858.CD008152.pub3. PMID: 22972117 Updated.
-
Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.Cochrane Database Syst Rev. 2014 Jan 20;2014(1):CD010927. doi: 10.1002/14651858.CD010927. Cochrane Database Syst Rev. 2014. PMID: 24443033 Free PMC article.
-
Post-discharge malaria chemoprevention in children admitted with severe anaemia in malaria-endemic settings in Africa: a systematic review and individual patient data meta-analysis of randomised controlled trials.Lancet Glob Health. 2024 Jan;12(1):e33-e44. doi: 10.1016/S2214-109X(23)00492-8. Lancet Glob Health. 2024. PMID: 38097295 Free PMC article.
-
The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data.Lancet Infect Dis. 2015 Jun;15(6):692-702. doi: 10.1016/S1473-3099(15)70024-1. Epub 2015 Mar 16. Lancet Infect Dis. 2015. PMID: 25788162 Free PMC article.
Cited by
-
Understanding the Intransigence of Malaria in Malawi.Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):40-48. doi: 10.4269/ajtmh.21-1263. Print 2022 Oct 11. Am J Trop Med Hyg. 2022. PMID: 36228915 Free PMC article.
-
Comparing approaches for chemoprevention for school-based malaria control in Malawi: an open label, randomized, controlled clinical trial.EClinicalMedicine. 2024 Sep 16;76:102832. doi: 10.1016/j.eclinm.2024.102832. eCollection 2024 Oct. EClinicalMedicine. 2024. PMID: 39318787 Free PMC article.
-
Genotyping of Anopheles mosquito blood meals reveals nonrandom human host selection: implications for human-to-mosquito Plasmodium falciparum transmission.Malar J. 2023 Apr 7;22(1):115. doi: 10.1186/s12936-023-04541-2. Malar J. 2023. PMID: 37029433 Free PMC article.
-
Malaria prevention in children: an update.Curr Opin Pediatr. 2024 Apr 1;36(2):164-170. doi: 10.1097/MOP.0000000000001332. Epub 2024 Jan 22. Curr Opin Pediatr. 2024. PMID: 38299986 Free PMC article. Review.
References
-
- World Health Organization (WHO). World malaria report 2019. Geneva: WHO, 2019. https://www.who.int/publications/i/item/9789241565721. Accessed 1 March 2020.